Deregulation of insulin signaling not only explains several metabolic aspects of PCOS—independently of the associated obesity—but contributes to modulating ovarian steroidogenesis towards a stable “androgenic” phenotype [6]. The gene discussed is INS; the disease is polycystic ovary syndrome.